Skip to main content
main-content

Pediatric rheumatology

Juvenile idiopathic arthritis

11-01-2019 | Juvenile idiopathic arthritis | News

News in brief

Predictors of outcomes identified in JIA-associated uveitis

Demographic factors, measures of disease activity, and the type of treatment used are associated with 2-year outcomes among patients with juvenile idiopathic arthritis-associated uveitis, according to findings from the ICON-JIA study.

Growing up right: Transitioning from pediatric to adult rheumatology care

Sangeeta Sule outlines the challenges of transitioning from pediatric to adult rheumatology care, highlights key resources to support families and healthcare providers, and provides tips on managing the transition process.

26-11-2018 | Juvenile idiopathic arthritis | News

Disease subtype, treatment choice may impact infection risk in JIA patients

Among biologic-treated patients with juvenile idiopathic arthritis, infection risk may differ according to disease subtype and the biologic agent used, researchers report.

Source:

Clin Rheumatol 2018; doi:10.1007/s10067-018-4367-9

09-11-2018 | Juvenile idiopathic arthritis | News

News in brief

Activity tracking ‘feasible’ for adolescents with JIA

Findings from a pilot study indicate that activity tracking using a wrist-worn device is a feasible approach for promoting physical activity in adolescent patients with juvenile idiopathic arthritis

Vaccination in children and adolescents with rheumatic conditions

In this editorial, the authors discuss the risks of live vaccination in children taking antirheumatic medications and how to manage these, as well as how health authorities can address decreasing vaccination coverage of the general public.

18-10-2018 | Infection | Editorial | Article

Vaccination in children and adolescents with rheumatic conditions

In this editorial, the authors discuss the risks of live vaccination in children taking antirheumatic medications and how to manage these, as well as how health authorities can address decreasing vaccination coverage of the general public.

Author:
NM Wulffraat, AM de Groot, EES Nieuwenhuis

15-10-2018 | Juvenile idiopathic arthritis | News

Response to canakinumab sustained for up to 5 years in children with sJIA

Response to canakinumab therapy is sustained or even improved for up to 5 years in children with systemic juvenile idiopathic arthritis, with no new safety signals, according to the results of a long-term extension study published in the Annals of the Rheumatic Diseases.

Source:

Ann Rheum Dis 2018; doi:10.1136/annrheumdis-2018-213150

01-10-2018 | Juvenile idiopathic arthritis | Review | Article

Glucocorticoid treatment in juvenile idiopathic arthritis

Batu ED. Rheumatol Int 2018. doi: 10.1007/s00296-018-4168-0

17-09-2018 | Juvenile idiopathic arthritis | Article

Reliability of ultrasonography to detect inflammatory lesions and structural damage in juvenile idiopathic arthritis

Ventura-Ríos L et al. Pediatr Rheumatol 2018; 16: 58. doi: 10.1186/s12969-018-0275-4

Cross-cultural adaptation and psychometric evaluation of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) in 54 languages across 52 countries: Review of the general methodology

The aim of this project was to cross-culturally adapt and validate the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) questionnaire in 54 languages across 52 different countries that are members of the Paediatric Rheumatology International Trials Organisation (PRINTO) [read more].
Bovis F et al. Rheumatol Int 2018; 38(Suppl 1): 5–17. doi: 10.1007/s00296-018-3944-1

Increased risk for preterm delivery in women with RA and JIA

Women with rheumatoid arthritis and those with juvenile idiopathic arthritis have a significantly elevated risk for preterm delivery, according to a prospective cohort study published in Arthritis Care & Research.

07-09-2018 | Treatment | Feature | Article

At a glance: Common scores used in rheumatology

A quick-reference guide to the scores that are commonly used in clinical trials and daily rheumatology practice.

06-09-2018 | Pregnancy | Highlight | News

Increased risk for preterm delivery in women with RA and JIA

Women with rheumatoid arthritis and those with juvenile idiopathic arthritis have a significantly elevated risk for preterm delivery, according to a prospective cohort study published in Arthritis Care & Research.

Source:

Arthritis Care Res 2018; doi:10.1002/acr.23730

21-08-2018 | Juvenile idiopathic arthritis | Article

Short-term outcomes in patients with systemic juvenile idiopathic arthritis treated with either tocilizumab or anakinra

Kearsley-Fleet L et al. Rheumatology (Oxford) 2018: key262. doi: 10.1093/rheumatology/key262

21-08-2018 | Pediatric | News

News in brief

Transition program may improve care for adolescents with rheumatic diseases

A dedicated clinical pathway may improve the transition from pediatric to adult care for adolescents with juvenile-onset rheumatic and musculoskeletal diseases, researchers report.

03-08-2018 | Pathophysiology | Review | Article

S100 proteins in rheumatic diseases

Austermann J, Spiekermann C, Roth J. Nat Rev Rheumatol 2018. doi: 10.1038/s41584-018-0058-9

02-08-2018 | Juvenile idiopathic arthritis | News

Support for early initiation of biologics in patients with severe JIA

Study results indicate that patients with severe juvenile idiopathic arthritis who start biologic DMARDs within 2 years of symptom onset have better long-term outcomes than those who begin treatment later.

Source:

Arthritis Care Res 2018; doi:10.1002/acr.23709

A multidisciplinary approach to managing chronic pain in children

Editorial board member Sangeeta Sule discusses the challenges faced when managing chronic pain in children and adolescents [read more].

image credits